APA (7th ed.) Citation

Isbarn, H., Budäus, L., Ahyai, S., Chun, F., Fisch, M., Dahlem, R., . . . Graefen, M. (2011). 670 CLINICAL STAGE AND THE BIOPSY GLEASON-SCORE SIGNIFICANTLY AFFECT THE RATE OF FAVORABLE HISTOPATHOLOGICAL STAGE AT RADICAL PROSTATECTOMY IN PATIENTS WITH VERY HIGH PREOPERATIVE PSA -VALUES (≥20 NG/ML). European Urology Supplements, 10(2), 215. https://doi.org/10.1016/S1569-9056(11)60658-1

Chicago Style (17th ed.) Citation

Isbarn, H., et al. "670 CLINICAL STAGE AND THE BIOPSY GLEASON-SCORE SIGNIFICANTLY AFFECT THE RATE OF FAVORABLE HISTOPATHOLOGICAL STAGE AT RADICAL PROSTATECTOMY IN PATIENTS WITH VERY HIGH PREOPERATIVE PSA -VALUES (≥20 NG/ML)." European Urology Supplements 10, no. 2 (2011): 215. https://doi.org/10.1016/S1569-9056(11)60658-1.

MLA (9th ed.) Citation

Isbarn, H., et al. "670 CLINICAL STAGE AND THE BIOPSY GLEASON-SCORE SIGNIFICANTLY AFFECT THE RATE OF FAVORABLE HISTOPATHOLOGICAL STAGE AT RADICAL PROSTATECTOMY IN PATIENTS WITH VERY HIGH PREOPERATIVE PSA -VALUES (≥20 NG/ML)." European Urology Supplements, vol. 10, no. 2, 2011, p. 215, https://doi.org/10.1016/S1569-9056(11)60658-1.